Ambrisentan 10 mg Australia

Description

Introduction

Ambrisentan 10 mg Australia contains ambrisentan, a medicine used in the treatment of pulmonary arterial hypertension (PAH). This condition involves increased blood pressure in the blood vessels carrying blood from the heart to the lungs. It can affect breathing, physical activity and everyday functioning.

Ambrisentan helps reduce narrowing of pulmonary blood vessels. Treatment requires appropriate medical assessment, ongoing monitoring and careful attention to safety precautions, particularly the serious risks associated with pregnancy.

What Is It?

Ambrisentan 10 mg contains the active ingredient ambrisentan at a stated strength of 10 mg. It belongs to a group of medicines called endothelin receptor antagonists, which act on a pathway involved in blood vessel constriction.

Ambrisentan is used for pulmonary arterial hypertension under medical supervision. The medicine is not appropriate for every type of pulmonary hypertension. Its suitability depends on an established diagnosis, medical history and specialist assessment.

How Does It Work?

Endothelin is a naturally occurring substance that causes blood vessels to narrow. Excessive activity of this pathway contributes to restricted blood flow in pulmonary arterial hypertension.

Ambrisentan blocks the effects of endothelin, helping pulmonary blood vessels relax and reducing resistance to blood flow. This action may improve exercise capacity and slow worsening symptoms in people with PAH.

Ambrisentan helps control the condition but does not provide a cure. Continued treatment and medical monitoring remain important.

Common Uses

Ambrisentan is used in the management of pulmonary arterial hypertension. PAH can interfere with normal physical activity and may cause significant limitations as the condition progresses.

• Management of pulmonary arterial hypertension in appropriately assessed patients.
• Improvement of exercise capacity in some people with PAH.
• Reduction in the rate of worsening PAH symptoms.
• Use alongside tadalafil when combination treatment is considered appropriate.

Ambrisentan may be prescribed alone or with tadalafil. Treatment decisions depend on individual clinical circumstances and specialist supervision.

Available Strengths

This family is available in 5 mg, 10 mg.

Key Features

• Active ingredient: ambrisentan.
• Declared strength: 10 mg.
• Medicine class: endothelin receptor antagonist.
• Clinical use: pulmonary arterial hypertension.
• May be used alone or with tadalafil.
• Requires medical supervision and appropriate monitoring.
• Important pregnancy-related safety restrictions apply.

Benefits

Ambrisentan may provide meaningful improvements in the management of pulmonary arterial hypertension, although treatment responses differ between individuals.

• May improve the ability to undertake physical exercise.
• Helps counteract endothelin-related blood vessel narrowing.
• May slow the worsening of PAH symptoms.
• Can form part of combination treatment with tadalafil.
• Supports ongoing management rather than curing PAH.

Clinical benefits must be considered alongside possible adverse effects and the need for regular assessment.

Possible Side Effects

Ambrisentan can cause side effects ranging from relatively mild symptoms to serious reactions requiring urgent assessment.

• Headache and flushing.
• Fast heartbeat or palpitations.
• Pale skin or unusual tiredness.
• Swelling affecting the hands, feet or ankles.
• Unexpected weight gain.
• Rash, itching or facial swelling.
• Nausea, vomiting or loss of appetite.
• Dark urine or yellowing of the skin or eyes.

Difficulty breathing, throat swelling, difficulty swallowing or severe allergic symptoms require emergency medical attention. Unexpected weight gain, extreme tiredness and symptoms suggesting liver problems require prompt medical assessment.

Precautions

Important safety considerations must be addressed before and throughout ambrisentan treatment.

• Pregnancy: ambrisentan can seriously harm an unborn baby and must not be taken during pregnancy.
• Contraception: reliable pregnancy prevention is required during treatment and for one month after stopping.
• Pregnancy testing: appropriate testing is required before treatment and during treatment when indicated.
• Breastfeeding: breastfeeding must be avoided while taking ambrisentan.
• Liver disease: current or previous liver problems require medical assessment.
• Anaemia: a history of low red blood cell counts should be discussed.
• Allergies: previous allergic reactions to ambrisentan or other medicines must be disclosed.

Additional Precautions

• Ambrisentan is generally unsuitable for people with idiopathic pulmonary fibrosis.
• Attend recommended medical appointments and laboratory tests.
• Report worsening breathing difficulties or unexpected swelling promptly.
• Seek immediate medical advice if pregnancy is suspected or a menstrual period is missed.
• Discuss future fertility concerns with the treating clinician.
• Inform healthcare professionals about existing conditions and current medicines.

Medicines similar to ambrisentan have been associated with reduced sperm counts in some men. Anyone concerned about future fertility should discuss this possibility with their clinician.

Storage Instructions

• Follow the storage directions accompanying the supplied medicine.
• Keep medication in its original container, securely closed.
• Protect medication from excessive heat and moisture.
• Avoid storing medicines in damp bathrooms.
• Keep medicines out of sight and reach of children.
• Ask a pharmacist about safe disposal of unwanted medication.

How to Take

Ambrisentan treatment must follow the prescription and instructions provided by the treating healthcare professional. General administration information for ambrisentan should not replace directions applicable to the supplied medicine.

• Follow the prescribed treatment schedule.
• Confirm administration instructions with the dispensing pharmacist.
• Do not independently increase or reduce the prescribed dose.
• Seek professional guidance if administration instructions are unclear.
• Never take a double dose to compensate for a missed dose.
• Do not discontinue treatment without consulting the prescriber.

Stopping ambrisentan without medical advice may result in worsening pulmonary arterial hypertension.

Drug Interactions

Other medicines may affect ambrisentan treatment or increase the possibility of unwanted effects.

• Ciclosporin may interact with ambrisentan and require treatment adjustment or monitoring.
• Tadalafil may be used alongside ambrisentan under medical supervision.
• Prescription and non-prescription medicines should be disclosed.
• Vitamins, herbal products and nutritional supplements should also be discussed.
• New medicines should be checked for possible interactions before use.

Why Choose This Product?

Ambrisentan 10 mg provides a stated 10 mg strength of ambrisentan for consideration when this ingredient and strength match a prescription. Appropriate selection requires confirmation by a qualified healthcare professional.

• Contains the declared active ingredient ambrisentan.
• Identifies the 10 mg strength.
• Belongs to an established medicine class used in PAH management.
• Requires appropriate medical assessment before treatment.
• Has important safety considerations requiring continued supervision.

The supplied medicine should be checked against the prescription and dispensing instructions before use.

Frequently Asked Questions (FAQs)

What is ambrisentan used for?

Ambrisentan is used to manage pulmonary arterial hypertension, a condition involving increased pressure in blood vessels supplying the lungs.

Does ambrisentan cure PAH?

No. It helps manage PAH symptoms but does not cure the underlying condition.

How does ambrisentan work?

It blocks the action of endothelin, helping reduce narrowing of pulmonary blood vessels.

Can ambrisentan improve exercise capacity?

Yes. Some people with PAH experience improved exercise capacity during treatment.

Is ambrisentan safe during pregnancy?

No. Ambrisentan can seriously harm an unborn baby. Pregnancy prevention and appropriate testing are essential.

Can ambrisentan cause swelling?

Yes. Swelling and unexpected weight gain can occur and may require prompt medical assessment.

Does ambrisentan require monitoring?

Yes. Medical reviews and appropriate laboratory testing are important throughout treatment.

Can ambrisentan interact with ciclosporin?

Yes. Ciclosporin can interact with ambrisentan, requiring professional assessment and possible treatment adjustment.

Can ambrisentan be combined with tadalafil?

Yes. The combination is used in some people with PAH under specialist supervision.

Can ambrisentan be stopped when symptoms improve?

No treatment changes should be made without medical advice. Stopping treatment may worsen the condition.

Related Products

• Ambrisentan 5 mg Australia
• Ambrisentan 10 mg Australia
• Riociguat 0.5 Mg Australia
• Bosentan 125 Mg Australia
• Atorvastatin 80 mg Australia
• Prazosin 5 mg Australia